NovaBridge Biosciences (NBP) Net Income (2019 - 2025)

NovaBridge Biosciences (NBP) has reported Net Income for 5 consecutive years, with -$103.8 million the latest figure, recorded in Q4 2025.

• Quarterly Net Income fell 208.85% year-over-year to -$103.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$105.6 million (down 176.32% YoY) and the FY2025 annual result came in at -$88.3 million, down 297.39% from the prior year.
• Net Income declined to -$103.8 million in Q4 2025 per NBP's latest filing, from $6.8 million in the prior quarter.
• Over the last five years, Net Income for NBP reached as high as $25.0 million in Q3 2023 and fell as low as -$103.8 million in Q4 2025.
• A 3-year average of -$13.2 million and a median of -$3.2 million in 2025 frame the typical range for Net Income.
• The largest YoY upside for Net Income was 199.47% in 2025 against a maximum downside of 1310576.19% in 2025.
• Year by year, Net Income stood at $25.0 million in 2023, then tumbled by 234.28% to -$33.6 million in 2024, then plunged by 208.85% to -$103.8 million in 2025.
• According to Business Quant data, Net Income over the past three periods registered -$103.8 million, $6.8 million, and -$5.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.